Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I single and multiple ascending dose study of OCID 2987 in healthy male volunteers
NL-OMON35806Phase 1Active, not recruiting
- Sponsor
- Orchid Research Laboratories
- Start
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in asthma and chronic obstructive pulmonary disease (COPD) comparing OCID 2987 with Placebo (2 arms). Primary endpoints: Safety and tolerability, Pharmacokinetics and 1 more. Started Mar 2011; status: active, not recruiting.
02
Drugs
OCID 2987
03
Conditions
asthmachronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NL-OMON35806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35806.